Literature DB >> 15115853

Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C.

Christilyn P Graff1, Kerry Chester, Richard Begent, K Dane Wittrup.   

Abstract

An scFv has been engineered to bind carcinoembryonic antigen (CEA) with a dissociation half-time >4 days at 37 degrees C. Two mutations responsible for this affinity increase were isolated by screening yeast surface-displayed mutant libraries by flow cytometry. Soluble expression of the mutant scFv in a yeast secretion system was increased 100-fold by screening mutant libraries for improved yeast surface display level. This scFv will be useful as a limiting case for evaluating the significance of affinity in tumor targeting to non-internalizing antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115853     DOI: 10.1093/protein/gzh038

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  45 in total

1.  Attainment of 15-fold higher affinity of a Fusarium-specific single-chain antibody by directed molecular evolution coupled to phage display.

Authors:  Jin-Long Liu; Zu-Quan Hu; Shu Xing; Sheng Xue; He-Ping Li; Jing-Bo Zhang; Yu-Cai Liao
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

Review 2.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

Review 3.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

4.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

5.  A general method for greatly improving the affinity of antibodies by using combinatorial libraries.

Authors:  Arvind Rajpal; Nurten Beyaz; Lauric Haber; Guido Cappuccilli; Helena Yee; Ramesh R Bhatt; Toshihiko Takeuchi; Richard A Lerner; Roberto Crea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

6.  Affinity-matured recombinant antibody fragments analyzed by single-molecule force spectroscopy.

Authors:  Julia Morfill; Kerstin Blank; Christian Zahnd; Beatrice Luginbühl; Ferdinand Kühner; Kay-E Gottschalk; Andreas Plückthun; Hermann E Gaub
Journal:  Biophys J       Date:  2007-08-03       Impact factor: 4.033

7.  An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.

Authors:  Eric J Lepin; Jeffrey V Leyton; Yu Zhou; Tove Olafsen; Felix B Salazar; Katelyn E McCabe; Scott Hahm; James D Marks; Robert E Reiter; Anna M Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-01       Impact factor: 9.236

8.  Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.

Authors:  Greg M Thurber; K Dane Wittrup
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.

Authors:  Itay Cohen; Olumide Kayode; Alexandra Hockla; Banumathi Sankaran; Derek C Radisky; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2016-03-08       Impact factor: 3.857

10.  The targeted delivery of interleukin-12 to the carcinoembryonic antigen increases the intratumoral density of NK and CD8+ T cell in an immunocompetent mouse model of colorectal cancer.

Authors:  Emanuele Puca; Caroline Schmitt-Koopmann; Marius Furter; Patrizia Murer; Philipp Probst; Manuel Dihr; Davor Bajic; Dario Neri
Journal:  J Gastrointest Oncol       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.